Abstract
α-Synuclein (αSN) is implicated in Parkinson's disease (PD) and is the major component of Lewy bodies (LBs). Although αSN is mainly expressed in neuronal cells and exists as a cytoplasmic protein, it has been found in body fluids including cerebrospinal fluid and blood. This study explored plasma αSN as a diagnostic marker for PD. Western blot analysis was used to characterize plasma αSN compared to brain αSN. Plasma αSN of 16 kDa migrates with the same mobility as its brain counterpart and recombinant αSN on denatured polyacrylamide gels and reacted with three different antibodies against the C-terminal and NAC regions of the αSN protein. The αSN levels in plasma from PD subjects are significantly lower than that in age-matched controls ( p = 0.001), and the αSN levels in patients with early-onset PD are lower than that in both late-onset PD and controls. This initial study indicates that measurement of αSN in plasma can provide support for a clinical diagnosis of Parkinson's disease and warrants further study in a larger population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
